UBS Group’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.7K | Buy |
28,026
+8,490
| +43% | +$4.75K | ﹤0.01% | 7283 |
|
|
2025
Q1 | $9.3K | Sell |
19,536
-17,560
| -47% | -$8.36K | ﹤0.01% | 7384 |
|
|
2024
Q4 | $37.5K | Buy |
37,096
+14,805
| +66% | +$15K | ﹤0.01% | 6260 |
|
|
2024
Q3 | $38.1K | Buy |
22,291
+8,196
| +58% | +$14K | ﹤0.01% | 5795 |
|
|
2024
Q2 | $35.9K | Sell |
14,095
-14,623
| -51% | -$37.3K | ﹤0.01% | 5795 |
|
|
2024
Q1 | $120K | Buy |
28,718
+3,125
| +12% | +$13.1K | ﹤0.01% | 4984 |
|
|
2023
Q4 | $85K | Buy |
25,593
+8,864
| +53% | +$29.4K | ﹤0.01% | 5076 |
|
|
2023
Q3 | $33.5K | Buy |
16,729
+2,715
| +19% | +$5.43K | ﹤0.01% | 5404 |
|
|
2023
Q2 | $44.3K | Buy |
14,014
+6,677
| +91% | +$21.1K | ﹤0.01% | 5478 |
|
|
2023
Q1 | $25.5K | Buy |
7,337
+1,884
| +35% | +$6.54K | ﹤0.01% | 5818 |
|
|
2022
Q4 | $28K | Buy |
+5,453
| New | +$28K | ﹤0.01% | 6142 |
|
|
2022
Q2 | – | Sell |
-32
| Closed | – | – | 9474 |
|
|
2022
Q1 | $0 | Sell |
32
-5,496
| -99% | – | ﹤0.01% | 9368 |
|
|
2021
Q4 | $88K | Buy |
5,528
+5,046
| +1,047% | +$80.3K | ﹤0.01% | 5349 |
|
|
2021
Q3 | $12K | Sell |
482
-550
| -53% | -$13.7K | ﹤0.01% | 6623 |
|
|
2021
Q2 | $30K | Buy |
+1,032
| New | +$30K | ﹤0.01% | 5855 |
|